Alpha Adrenergic and Serotonergic Agents in the Treatment of Spastic Hypertonia - 15/07/18
Résumé |
It is important to consider many steps in the treatment of patients with problematic spasticity: establish the functional impact of the spasticity; identify the functional goal to be achieved by treatment; eliminate any remediable spasticity aggravating factors; evaluate the effects of previous antispasticity treatments; consider nonpharmacologic and pharmacologic treatments; initiate therapy with a low dosage; titrate judiciously; stop the titration when function goal is achieved; and if goal is not achieved or if side effects are intolerable, consider a second medication.
Le texte complet de cet article est disponible en PDF.Vol 12 - N° 4
P. 889-906 - novembre 2001 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?